Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hematologic Neoplasms × Blood Cell Count × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Standard of Care 9 Exercise 8 Practice Guidelines as Topic 7 Blood Specimen Collection 7 Educational Status 6 Palliative Care 5 Methods 5 Behavior Therapy 5 fludarabine 4 Surveys and Questionnaires 4 Physical Therapy Modalities 4 Early Intervention, Educational 4 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Health Promotion 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 pegylated granulocyte colony-stimulating factor 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Therapeutic Touch 2 Stem Cell Transplantation 2 Restraint, Physical 2 Radiosurgery 2 Parenteral Nutrition 2 Low-Level Light Therapy 2 Etoposide 2 Cytarabine 2 Control Groups 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04454723 2024-03-05

PalliaQOL

University of Oklahoma

Phase NA Completed

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡